The Innovators in Science Award, proudly sponsored by the Takeda Pharmaceutical Company Limited and administered by the New York Academy of Sciences, was established on November 10, 2016 and recognizes a promising Early Career Scientist and an outstanding Senior Scientist’s contributions to science in the therapeutic areas of Neuroscience, Gastroenterology, Regenerative Medicine, and Oncology, and is intended to support their commitment to innovative research.
Two prizes of US$200,000 are awarded each year, in a specific therapeutic area, one to an Early Career Scientist and the other to a well-established Senior Scientist from across the globe who have distinguished themselves for the creative thinking and impact of their research.
In 2017, Nominate Early Career and Senior Scientists in Neuroscience.
The nominations submission portal will open March 15, 2017 and close April 26, 2017 at 11:59PM EST.
"As Takeda continues to embrace innovative science and thinking within our own organization, we look outward to honor those who are leading the way as an inspiration in our pursuit. We are privileged to partner with The New York Academy of Sciences to create the Innovators in Science Award, and look forward to recognizing and supporting the awardees' contributions to transformative research."
— Andrew Plump, MD, PhD
Chief Medical and Scientific Officer
Takeda Pharmaceutical Company Limited
"As the New York Academy of Sciences enters its Third Century of Innovation, the Innovators in Science Award will serve as an iconic example of our long-standing tradition of partnering with prestigious global partners to advance science and address the challenges confronting our planet. So we are delighted to call Takeda partners in the drive to improve human health through innovation."
— Ellis Rubinstein
President and Chief Executive Officer
The New York Academy of Sciences
Nominations are invited from the academic institutions listed here. In addition, we also welcome nominations from government or non-profit institutions or equivalent around the world, as well as from the Awards’ own Scientific Advisory Council, composed of renowned science and technology leaders. If your institution is not listed here and would like to nominate, we welcome submission of a brief statement of interest to TakedaInnovators@nyas.org.
Prize Winners and Finalists will be selected by a panel of independently selected judges with expertise in these disciplines.
The Awards will be conferred at a formal ceremony in New York City or Japan each fall. The inaugural Winners and Finalists will be honored at an Awards Ceremony and Symposium at the New York Academy of Sciences in November 2017.
Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as our presence in Emerging Markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. For more information, visit http://www.takeda.com/news.
Proudly Sponsored by: